dextromethorphan quinidine Nuedexta
Selected indexed studies
- Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use. (Pharmacol Ther, 2016) [PMID:27139517]
- Management of Behavioral and Psychological Symptoms of Dementia. (Curr Psychiatry Rep, 2019) [PMID:31264056]
- Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia. (World J Psychiatry, 2020) [PMID:32399396]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use. (2016) pubmed
- Management of Behavioral and Psychological Symptoms of Dementia. (2019) pubmed
- Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia. (2020) pubmed
- Dextromethorphan-Quinidine (Nuedexta) Improves Swallowing in Bulbar Onset ALS Patients With Pseudobulbar Affect - Pre-Post Observational Study in 86 ALS Patients (P4.4-019). (2023) pubmed
- Dextromethorphan/quinidine withdrawal-emergent catatonia. (2016) pubmed
- Dextromethorphan/quinidine: in pseudobulbar affect. (2011) pubmed
- A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia. (2024) pubmed
- Dextromethorphan/quinidine for the treatment of pseudobulbar affect. (2014) pubmed
- Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect. (2015) pubmed
- Dextromethorphan/quinidine: AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan. (2005) pubmed